TIM-3 Participates in the Invasion and Metastasis of Nasopharyngeal Carcinoma via SMAD7/SMAD2/SNAIL1 Axis-Mediated Epithelial-Mesenchymal Transition

被引:21
作者
Xiao, Yangyang [1 ]
Qing, Jilin [2 ]
Li, Baoxuan [3 ]
Chen, Liuyan [1 ]
Nong, Shengzhou [1 ]
Yang, Wenhui [1 ]
Tang, Xiaogang [4 ]
Chen, Zhizhong [1 ]
机构
[1] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Clin Lab, 6 Taoyuan Rd, Nanning 530021, Guangxi, Peoples R China
[2] Peoples Hosp Guangxi Zhuang Autonomous Reg, Ctr Reprod Med & Genet, Nanning 530021, Guangxi, Peoples R China
[3] Binzhou Med Univ Hosp, Dept Ophthalmol, Binzhou 256603, Shandong, Peoples R China
[4] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Intens Care Unit, Nanning 530021, Guangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
nasopharyngeal carcinoma; T-cell immunoglobulin and mucin-domain containing molecule-3; invasion; metastasis; epithelial-mesenchymal transition; CANCER; EXPRESSION; PROMOTES; RECEPTOR; SMAD7;
D O I
10.2147/OTT.S237222
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: T-cell immunoglobulin and mucin domain-containing molecule-3 (TIM-3) was originally found to negatively regulate immune response and mediate immune escape in tumors. Subsequently, an increasing body of evidence has shown that TIM-3 exerts positive functions in the development and progression of several tumors. However, the role of TIM-3 in nasopharyngeal carcinoma (NPC) remains unknown. Methods: Data from the Cancer Genome Atlas-head and neck squamous cell carcinoma and immunohistochemistry were analyzed to compare the expression of TIM-3 in NPC and noncancerous nasopharyngitis tissues. Cell proliferation was evaluated using the Cell counting kit-8 in vitro and xenograft experiment in nude mice in vivo. Flow cytometry was used to evaluate the cell cycle. The migration and invasion of NPC cells were assessed through wound healing and Transwell assays. In addition, Western blotting was used to analyze the expression of specific proteins. Results: Higher expression of TIM-3 was detected in NPC tissues than normal nasopharyngeal tissues and positively con elated with the clinical stage and T classification; however, it was not correlated with gender, age, and N classification. Furthermore, overexpression of TIM-3 using lentiviral vectors increased the malignancy of 6-10B and CNE-2 cell lines that lowly express TIM-3, by promoting cell proliferation, migration, and invasion in vitro and in vivo. In addition, overexpression of TIM-3 was associated with upregulation of matrix metalloproteinase 9 (MMP9) and MMP2, and led to epithelial-mesenchymal transition (EMT) by increasing the levels of mesenchymal markers (ie, N-cadherin, Vimentin) and decreasing those of the epithelial marker E-cadherin. Further study showed that SMAD7 was downregulated in the TIM-3 overexpression group. Relatively, phosphorylated SMAD2 and downstream molecule SNAIL1 were also upregulated in this group. Conclusion: TIM-3 exerts a tumor-promoting function in NPC by mediating changes in the SMAD7/SMAD2/SNAIL1 axis. These findings provide a new idea for the study of invasion, metastasis, and treatment of NPC.
引用
收藏
页码:1993 / 2006
页数:14
相关论文
共 46 条
[1]   Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells [J].
Anderson, Ana C. ;
Anderson, David E. ;
Bregoli, Lisa ;
Hastings, William D. ;
Kassam, Nasim ;
Lei, Charles ;
Chandwaskar, Rucha ;
Karman, Jozsef ;
Su, Ee W. ;
Hirashima, Mitsuomi ;
Bruce, Jeffrey N. ;
Kane, Lawrence P. ;
Kuchroo, Vijay K. ;
Hafler, David A. .
SCIENCE, 2007, 318 (5853) :1141-1143
[2]   Tim-3: An Emerging Target in the Cancer Immunotherapy Landscape [J].
Anderson, Ana C. .
CANCER IMMUNOLOGY RESEARCH, 2014, 2 (05) :393-398
[3]   Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion [J].
Bourboulia, Dimitra ;
Stetler-Stevenson, William G. .
SEMINARS IN CANCER BIOLOGY, 2010, 20 (03) :161-168
[4]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[5]  
Cao Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053834, 10.1371/journal.pone.0055021]
[6]   Nasopharyngeal cancer: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].
Chan, A. T. C. ;
Gregoire, V. ;
Lefebvre, J. -L. ;
Licitra, L. ;
Hui, E. P. ;
Leung, S. F. ;
Felip, E. .
ANNALS OF ONCOLOGY, 2012, 23 :83-85
[7]   UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses [J].
Chandrashekar, Darshan S. ;
Bashel, Bhuwan ;
Balasubramanya, Sai Akshaya Hodigere ;
Creighton, Chad J. ;
Ponce-Rodriguez, Israel ;
Chakravarthi, Balabhadrapatruni V. S. K. ;
Varambally, Sooryanarayana .
NEOPLASIA, 2017, 19 (08) :649-658
[8]   The immunologic advantage of recurrent nasopharyngeal carcinoma from the viewpoint of Galectin-9/Tim-3-related changes in the tumour microenvironment [J].
Chen, Tseng-Cheng ;
Chen, Chao-Hsien ;
Wang, Cheng-Ping ;
Lin, Pei-Hsuan ;
Yang, Tsung-Lin ;
Lou, Pei-Jen ;
Ko, Jenq-Yuh ;
Wu, Chen-Tu ;
Chang, Yih-Leong .
SCIENTIFIC REPORTS, 2017, 7
[9]   Nasopharyngeal carcinoma [J].
Chen, Yu-Pei ;
Chan, Anthony T. C. ;
Quynh-Thu Le ;
Blanchard, Pierre ;
Sun, Ying ;
Ma, Jun .
LANCET, 2019, 394 (10192) :64-80
[10]   Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials [J].
Chen, Yu-Pei ;
Tang, Ling-Long ;
Yang, Qi ;
Poh, Sharon-Shuxian ;
Hui, Edwin P. ;
Chan, Anthony T. C. ;
Ong, Whee-Sze ;
Tan, Terence ;
Wee, Joseph ;
Li, Wen-Fei ;
Chen, Lei ;
Ma, Brigette B. Y. ;
Tong, Macy ;
Tan, Sze-Huey ;
Cheah, Shie-Lee ;
Fong, Kam-Weng ;
Sommat, Kiattisa ;
Soong, Yoke Lim ;
Guo, Ying ;
Lin, Ai-Hua ;
Sun, Ying ;
Hong, Ming-Huang ;
Cao, Su-Mei ;
Chen, Ming-Yuan ;
Ma, Jun .
CLINICAL CANCER RESEARCH, 2018, 24 (08) :1824-1833